Exocrine Proteins Including Trypsin(ogen) as a Key Biomarker in Type 1 Diabetes
Preprint
- 20 June 2022
- preprint
- Published by Elsevier in SSRN Electronic Journal
Abstract
Background: Proteomic profiling can identify useful biomarkers and monozygotic (MZ) twins, discordant for a condition represent the ideal test population. We aimed to investigate and validate proteomic profiling in twins with type 1 diabetes (T1D) and in other well characterised cohorts. Methods: A broad, multiplex analysis of 4068 proteins in sera from MZ twin pairs concordant (n=43) and discordant for T1D (n=27) identified major differences which were subsequently validated by a trypsin(ogen) assay in MZ pairs concordant (n=39) and discordant (n=42) for T1D,individuals at-risk (n=195) and with T1D (n=990), as well as with non-insulin requiring adult-onset diabetes diagnosed with either autoimmune (ADA)(n=96) or type 2 diabetes (T2D) (n=291). Findings: Proteomic analysis identified major differences between exocrine enzyme levels in discordant MZ twin pairs despite strong correlation between twins, whether concordant or discordant for T1D (P<0∙01 for both). In validation experiments, trypsin(ogen) levels were lower in T1D twins compared with non-diabetic co-twins (p<0∙0001) and healthy controls (p=0∙0002). In recently-diagnosed cases, trypsin(ogen) levels were lower than in controls across a broad age range. In at-risk relatives, levels <15 ng/ml were associated with increased risk of progression (uncorr. p=0∙009). Multiple linear regression in recently-diagnosed cases showed that trypsin(ogen) levels are associated with insulin dose and diabetic ketoacidosis while age and BMI are major confounders. Interpretation: T1D is associated with altered exocrine function, even before clinical onset. Twin data suggest roles for genetic and non-genetically determined factors. Exocrine/endocrine interactions are important under-investigated factors in T1D. Funding: Diabetes UK, JDRF, British Diabetic Twin Trust, Barts Charity and EU(FP7). Declaration of Interest: The authors declare no conflict of interest. Ethical Approval: The BOX study is approved by the South Central–Oxford C National Research Ethics Committee (REC) (Ref: 15/SC/0310) while the ADDRESS-2 study has ethical approval from South Central-Berkshire REC (Ref: 10/H0505/85). Analysis of samples from the ENDIT cohort have been approved by Wales REC 6 (Ref: 19/WA/0295). The twins study was approved by Northern and Yorkshire REC (Ref: 06/MRE03/22). Adult-onset diabetes samples were approved by the UK National Research Ethics Committee (Ref:P/02/240). All participants provided informed consent either personally or by parental consent, as appropriate as mandated by the Declaration of Helsinki.Keywords
This publication has 24 references indexed in Scilit:
- Insulitis and characterisation of infiltrating T cells in surgical pancreatic tail resections from patients at onset of type 1 diabetesDiabetologia, 2015
- Abnormalities of the Exocrine Pancreas in Type 1 DiabetesCurrent Diabetes Reports, 2015
- Adult-Onset Autoimmune Diabetes in Europe Is Prevalent With a Broad Clinical PhenotypeDiabetes Care, 2013
- Pancreatic Volume Is Reduced in Adult Patients with Recently Diagnosed Type 1 DiabetesThe Journal of Clinical Endocrinology & Metabolism, 2012
- Reference Intervals for and Validation of Recalibrated Immunoassays for Trypsinogen-1 and Trypsinogen-2Clinical Chemistry, 2012
- Rising Incidence of Type 1 Diabetes Is Associated With Altered Immunophenotype at DiagnosisDiabetes, 2012
- Pancreas volumes in humans from birth to age one hundred taking into account sex, obesity, and presence of type‐2 diabetesClinical Anatomy, 2007
- Magnetic resonance imaging: a reliable method for measuring pancreatic volume in Type 1 diabetesDiabetic Medicine, 2007
- Heterogeneity of Type I diabetes: analysis of monozygotic twins in Great Britain and the United StatesDiabetologia, 2001
- Value of Antibodies to Islet Protein Tyrosine Phosphatase–Like Molecule in Predicting Type 1 DiabetesDiabetes, 1997